Cassava Sciences Inc
SAVA
NASDAQ. Currency in USD
38.10 -0.60 ( -1.55% )
Market Cap.
1.59B
Beta (5Y monthly)
0.03
Price/Earnings
-
EPS (TTM)
-1.78
Forward Dividend
0.00 (0.00%)
Ex-Dividend Date
Dec 17, 2012
Volume
713,619
1y Target Est.
69.75
Day's Range
52 Week's Range
Historical Summary
Performance
1 Month
14.31%
YTD
-12.81%
1Y
-11.95%
2Y
373.88%
117.80% ann.
3Y
1,905.26%
171.62% ann.
EPS growth
1Y
-223.64%
2Y
-641.67%
-132.96% ann.
3Y
-709.09%
-82.63% ann.
5Y
5.31%
1.04% ann.
10Y
-535.94%
-15.87% ann.
20Y
54.59%
2.20% ann.
Share Buybacks
3 Months
0.12%
6 Months
-0.22%
1Y
-0.23%
2Y
-60.38%
3Y
-133.36%
5Y
-512.57%
10Y
-528.57%
20Y
-934.72%
About Cassava Sciences Inc
Sector
Healthcare
Industry
Biotechnology
Website
https://www.cassavasciences.com
Exchange
NASDAQ (XNAS)
Shares Outstanding
40.02M
Employees
24
Address
7801 North Capital of Texas Highway, Austin, TX, United States, 78731
Latest news

Is Anavex Life Sciences a Buy?
It still needs to prove that its lead program is as effective as it claims...
By The Motley Fool - 7 weeks ago

Tesla, Apple, GameStop, Prometheus Biosciences, Cassava Sciences: Why These 5 Stocks Are Drawing Investors' Attention Today
U.S. markets continued their weak trend on Wednesday, with next week’s Federal Open Market Committee...
By Benzinga - 8 weeks ago
Cassava Sciences Announces Completion of Dosing in Open-label Study of Simufilam for Alzheimer’s Disease
AUSTIN, Texas, Dec. 06, 2022 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc. (Nasdaq: SAVA), a clinical-stage...
By GlobeNewswire Inc. - 8 weeks ago
Cassava Sciences Announces Closing of $50 Million Registered Direct Offering
AUSTIN, Texas, Nov. 22, 2022 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc. (Nasdaq: SAVA) (the “Company”...
By GlobeNewswire Inc. - 10 weeks ago
Cassava Sciences Announces $50 Million Registered Direct Offering of Common Stock
AUSTIN, Texas, Nov. 18, 2022 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc. (Nasdaq: SAVA) (the “Company”...
By GlobeNewswire Inc. - 11 weeks ago
Cassava Sciences Reports Third Quarter Financial Results for 2022 and Business Updates
– $174.7 Million Cash and Cash Equivalents at September 30, 2022 –
By GlobeNewswire Inc. - 12 weeks ago
Short sellers hit back at Cassava lawsuit against them: ‘We stand behind everything we wrote’
The defendants at the heart of a lawsuit from meme stock Cassava have hit back...
By MarketWatch - 13 weeks ago
Short sellers hit back at Cassava lawsuit against them: ‘We stand behind everything we wrote’
The defendants at the heart of a lawsuit from meme stock Cassava have hit back...
By MarketWatch - 13 weeks ago